Aim: Serum high molecular weight (HMW) adiponectin improves insulin sensitivity, and a decreased level has been reported as a risk factor for the development of diabetes and coronary heart disease. This association may be further confounded by smoking, which is involved in the development of insulin resistance. The aim of this study was to determine whether smoking status is associated with serum HMW adiponectin levels in community-dwelling males. 
coronary heart disease (CHD) 2) . Adiponectin is a 247-amino acid protein containing four different domains that regulates the metabolism of lipids and glucose. Studies have found adiponectin to have anti-inflammatory, antiatherogenic, and antidiabetic properties 3) . Moreover, Waki et al. 4) recently demonstrated that adiponectin forms multimers and is present in serum as a trimer, hexamer, or high molecular weight (HMW) form, the latter being the most active form. In nondiabetic or diabetic subjects, HMW adiponectin levels have greater statistical power for the prediction of insulin resistance and metabolic syndrome than plasma total adiponectin levels [5] [6] [7] .
Introduction
Adiponectin, a protein secreted specifically by adipose tissue, improves insulin sensitivity 1) , and a decreased serum adiponectin level has been reported as a risk factor for the development of diabetes and
Smoking is a major health problem that increases morbidity and mortality as it is associated with several types of cancer (i.e., lung cancer, esophageal cancer), CHD, and pulmonary disease (i.e., chronic obstructive lung disease). Smoking has also been known to affect adipocytokines and to cause decreases in adiponectin levels 8) . However, body weight is decreased by a weight-lowering effect via an anorectic mechanism induced by nicotine 9) . This association may be further confounded by smoking status which is involved in the development of both insulin resistance and a weight-lowering effect. There is a great deal of controversy surrounding this relationship, and information on the relationship between the influence of smoking and serum adiponectin on the development of insulin resistance is sparse 8, [10] [11] [12] . To our knowledge, few studies have examined the relationship between smoking status and serum HMW adiponectin levels.
We hypothesized that the serum HMW adiponectin level in smokers is associated with smoking status regardless of insulin resistance and body weight. We evaluated whether smoking status is associated with decreased adiponectin levels, using cross-sectional data on community-dwelling men.
Materials and Methods

Subjects
Participants were recruited at an annual physical examination in a rural town with a total population of 11,136 (as of April 2002), located in Ehime prefecture, Japan, in 2002. Among the 9,133 adults (4,395 males) aged 19 to 90 years in this population, a random sample of 3,164 (34.6%) subjects was recruited. Information on medical history, present conditions, and drugs was obtained by interview. The prevalence of never-smokers among women was 97.4%; women were therefore excluded. Subjects with a clinical history of diabetes were also excluded from the study. The final study sample consisted of 724 eligible men. All procedures were approved by the Ethics Committee of Ehime University School of Medicine.
Evaluation of Risk Factors
Information on demographic characteristics and risk factors was collected using clinical files. Body mass index was calculated by dividing weight (in kilograms) by the square of height (in meters). Blood pressure was measured in the right upper arm of participants in a sedentary position using an automatic oscillometric blood pressure recorder (BP-103i; Colin, Aichi, Japan) after they had rested for at least 5 min. Total cholesterol (T-C), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), fasting blood glucose (FBG), uric acid, immuno-reactive insulin (IRI), serum gamma glutamyltransferase (GGT), and high molecular weight (HMW) adiponectin (FUJIRE-BIO, Tokyo, Japan) levels were measured during fasting. Low-density lipoprotein cholesterol (LDL-C) levels were calculated using the Friedewald formula 13) . Participants with TG levels ≥ 400 mg/dL were excluded. Homeostasis of minimal assessment of insulin resistance (HOMA-IR) was calculated from FBG and IRI levels using the formula FBG (mg/dL) IRI (mU/mL)/ 405, and a borderline level of Insulin resistance was defined as HOMA-IR ≥ 1.6 14) . The glomerular filtration rate was estimated using the equation eGFR 194 Cr 1.094 Age 0. 287 15) . Other characteristics, e.g., smoking and alcohol habits, and medication were investigated by individual interviews using a structured questionnaire. Smoking status was defined as the number of cigarette packs per day multiplied by the number of years smoked (pack • year), and daily alcohol consumption was measured using the Japanese liquor unit which corresponds to 22.9 g of ethanol.
Statistical Analysis
The statistical analysis was performed using SPSS 10.0J (Statistical Package for Social Science, Inc., Chicago, IL, USA). All values are expressed as the mean standard deviation (SD), unless otherwise specified. Data on TG, FBG, HOMA-IR, serum GGT, and HMW adiponectin levels were skewed and log-transformed for analysis. Differences based on smoking status (never-smokers, ex-smokers, light-smokers ( 30 pack • year) and heavy-smokers ( ≥ 30 pack • year)) were analyzed with the Kruskal Wallis test or chi-square ( 2 ) test. Pearson's partial correlation coefficient, after adjustments for age, was calculated in order to characterize associations between various characteristics and serum HMW adiponectin levels because the levels increased with age 7) . A multiple linear regression analysis was used to evaluate the contribution of each confounding factor to serum HMW adiponectin levels 8, 10, 12, [16] [17] [18] [19] . An ANCOVA was performed using a general linear model to determine the association between confounding factors and serum HMW adiponectin levels. In these analyses, serum HMW adiponectin was the dependent variable, the four categories of smoking status were the fixed factors, and age, BMI, alcohol consumption, and HOMA-IR were added as covariates. A value of p 0.05 was considered significant. Table 1 shows the characteristics of each subject's background factors categorized according to smoking status. The subjects comprised 724 men aged 60 14 (mean standard deviation) (range, 20 − 89) years, 302 (41.7%) of which were defined as never-smokers, 172 (23.8%) as ex-smokers, 106 (14.6%) as light-smokers, and 144 (19.9%) as heavy-smokers. Body mass index, systolic blood pressure (SBP), antihypertensive medication, and LDL-C were lower, but TG, serum GGT, and eGFR were higher in the current smokers than in the never-and ex-smokers. There were no inter-group differences regarding HDL-C, antilipidemic medication, uric acid, and HOMA-IR.
Results
Mean serum HMW adiponectin levels were sig- nificantly lower in the current smokers than in neverand ex-smokers, but were not significantly different between the light and heavy-smokers ( Table 2 ).
In the subjects overall, the age-adjusted Pearson's partial correlation coefficient showed that levels of serum HMW adiponectin were inversely associated with BMI, alcohol consumption, SBP, DBP, TG, LDL-C, FBG, uric acid, serum GGT, and HOMA-IR, while directly associated with HDL-C and eGFR ( Table 3 ). In the current smokers, the number of cigarettes/day was 0.139 and statistically significant (p 0.028) (data not shown).
To further investigate whether smoking status can explain the serum HMW adiponectin levels independent of other known confounding factors, multiple linear regression analyses for serum HMW adiponectin were performed with three models (Table 4 . Fig. 1 indicates log levels of HMW adiponectin in serum after adjustments for confounding factors in Model 3 of Table 4 . Serum HMW adiponectin levels were significantly low in the heavy-smokers.
Next, to control potential confounding by obesity, and insulin resistance, the data were further stratified by age, BMI, alcohol consumption, and HOMA-IR ( Table 5) . Mean log serum HMW adiponectin levels were significantly and similarly decreased in heavy-smokers compared with never-smokers and ex-smokers of an age ≥ 60 years, BMI ≥ 22 kg/m 2 , and HOMA-IR ≥ 1.6. However, there were no significant differences between the two groups for each characteristic.
Discussion
To examine the possible contribution of smoking to decreasing serum HMW adiponectin levels in community-dwelling males, we studied the relationship between potential confounders and serum HMW adiponectin levels in subjects categorized by smoking status. Multiple linear regression analyses revealed smoking status to be significantly associated with serum . Data for triglycerides, serum gamma glutamyltransferase, HOMA-IR, and serum HMW adiponectin were skewed, and log-transformed for analysis. r, Pearson's correlation coefficient. HMW, high molecular weight; HDL, high-density lipoprotein; LDL, low-density lipoprotein; HOMA-IR, Homeostasis of minimal assessment of insulin resistance; eGFR, estimated glomerular filtration rate. Body mass index was calculated using weight in kilograms divided by the square of height in meters. Alcohol consumption was measured using the Japanese unit which corresponds to 22.9 g of ethanol (never-drinkers, light-drinkers ( 1 unit/day), moderate heavy-drinkers ( ≥ 1 unit/day)). Smoking status: daily consumption (pack) duration of smoking (year) (neversmokers, ex-smokers, light-smokers ( 30 pack • year) and heavy-smokers ( ≥ 30 pack • year)). HOMA-IR was calculated using the formula; fasting blood glucose (mg/dL) immuno-reactive insulin (mU/mL)/405. eGFR was estimated using the equation: 194 Cr 1.094 Age 0.287
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. Data for triglycerides, serum gamma glutamyltransferase, and HMW adiponectin were skewed and log-transformed for analysis. , standard coefficient. HMW adiponectin levels as well as age, BMI, alcohol consumption, and HOMA-IR. The present study also showed a dose-dependent relationship between the amount smoked and serum HMW adiponectin levels in community-dwelling Japanese men. In this study, the relationship between serum adiponectin levels and confounding factors was consistent with previous findings in that the serum adiponectin concentration was significantly associated with age, BMI, BP 16) , TG, HDL-C, atherogenic index 17) , FBG, 2h-BS, HOMA-IR 18) , and eGFR 19) even in participants without diabetes. Moreover, physical activity and dietary factors as well as smoking status were shown to be independently related to serum adiponectin levels in Japanese men 11) . Adiponectin is considered an important modulator of insulin sensitivity 18) and dyslipidemia 17) , and its levels are also increased by weight reduction, and medications such as thiazolidinedione compounds 20, 21) , angiotensin converting enzyme inhibitors, and angiotensin receptor blockers 22) that improve insulin sensitivity at the cellular level. So, we excluded male participants with a history of diabetes and used a multiple regression analysis to examine the association between smoking status and serum HMW adiponectin with adjustments made for age, BMI, alcohol consumption, smoking status, lipids, serum GGT, HOMA-IR, eGFR, and antihypertensive and antilipidemic medication. Serum adiponectin levels have been shown to be lower in smokers than in non-smokers 8, 10, 23) . For example, they were lower in current and ex-smokers than never-smokers both before and after adjustments for age and adiposity (p 0.002 and p 0.008, respectively), and did not differ significantly according to alcohol drinking status 23) . Serum adiponectin levels were found to be lower among both male and female smokers than never-smokers (p 0.001), and this relation appeared to be dose-dependent in men (p for trend 0.006 in the multivariate-adjusted model). Men who quit smoking for 20 years and women for 10 years had an adiponectin concentration similar to that observed in never-smokers 10) . After adjusting for age, BMI, and alcohol consumption, mean log adiponectin levels were decreased in current smokers compared with never-smokers (p 0.0190). The relationship between adiponectin and smoking was similar between high and low insulin resistance, BMI, and waist circumference groups 12) . In our study, mean log serum HMW adiponectin levels were significantly decreased in heavy-smokers compared with neversmokers and ex-smokers in the high insulin resistance groups such as subjects of age ≥ 60 years, BMI ≥ 22.0 HMW, high molecular weight; HOMA-IR, Homeostasis of minimal assessment of insulin resistance. Body mass index (BMI) was calculated using weight in kilograms divided by the square of height in meters. Alcohol consumption was measured using the Japanese unit which corresponds to 22.9 g of ethanol. HOMA-IR was calculated using the formula; fasting blood glucose (mg/dL) immuno-reactive insulin (mU/mL)/405. Data for HOMA-IR, and HMW adiponectin were skewed, and log-transformed for analysis. Each category was adjusted for confounding factors in Model 3 of Table 4 , and HOMA-IR ≥ 1.6. Serum HMW adiponectin levels are reported to increase linearly with age 7) , and decrease with elevated BMI and HOMA-IR 5, 6) . Under such conditions, factors such as oxidative stress and the production of tumor necrosis factor (TNF)-and c-reactive protein (CRP) induced by chronic exposure to cigarette smoke may promote the development of hypoadiponectinemia.
Several experimental studies have investigated the effect of chronic smoking on serum adiponectin levels, and the mechanism by which smoking acts on HMW adiponectin in serum has been studied extensively. Smoking has been known to be associated with increased oxidative stress and nicotine. Oxidative stress can damage many cell components and functions, including DNA, mitochondrial metabolism, lipid, and protein 24, 25) . Iwashima et al. 8) demonstrated that H2O2 and nicotine generated by smoking reduced mRNA expression and secretion of adiponectin in a dosedependent manner in cultured mouse 3T3-L1 adipocytes. Several studies also suggest that smoking induces production of inflammatory cytokines such as TNFand CRP 26) that are risk factors for atherosclerosis. Increased levels of TNF-and C-reactive protein (CRP) induce the production of ROS (reactive oxygen species), resulting in endothelial dysfunction under many pathophysiological conditions 27, 28) . TNF-, whose produced is increased in an insulin-resistant state, also dose-dependently suppresses the expression of adiponectin in adipocytes by suppressing promoter activity 29) . These results provide a plausible explanation for our findings of a relationship between the amount of tobacco smoked and serum HMW adiponectin levels.
Some limitations of this study must be considered. First, the response rate (35%) was low, as in other conventional community studies in Japan. However, the relatively large sample size enabled assessment of an extensive array of smoking habits in relation to serum HMW adiponectin levels. Second, the crosssectional study design is limited in its ability to eliminate causal relationships between smoking status and HMW adiponectin. Third, a single assessment of serum HMW adiponectin levels may be susceptible to short-term variation and this may introduce misclassification bias. Fourth, this study was done only in men because there are few female smokers in Japan. Fifth, this study, as well as other studies, relied on the selfreporting of smoking status, which may result in error and bias. Finally, the demographics and referral source may limit generalization of the results.
In conclusion, the present study showed that smoking status was associated with decreased serum HMW adiponectin levels in community-dwelling males independent of traditional cardiovascular risk factors such as age, alcohol consumption, HOMA-IR, and eGFR. For community-dwelling men, prospective population-based studies are needed to investigate the mechanisms underlying this association.
